Good bye and good riddance
I hated anthracyclines and they didn't seem to do that much judging from the MRIs. Nearly five years after diagnosis, I assume that it was the taxotere or herceptin that worked.
Too many women have been rendered ineligible for herceptin because their hearts were damaged by anthracyclines previously.
I suppose that the other oncologists are holding off until they can run a trial that proves this (knowing how conservative they can be).
In general, there needs to be a lot more of this type of research since too many women are getting drugs that don't benefit them and have extreme side effects. Fortunately, I think that medical researchers realise this.
|